BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Osseon Therapeutics, Inc. Closes $14 Million Equity Financing


1/31/2013 8:51:59 AM

SANTA ROSA, Calif., Jan. 31, 2013 /PRNewswire/ -- Osseon® Therapeutics, Inc. announced today that it has raised a $14 million round of equity financing led by a private investor. The proceeds will allow Osseon to expand its VCF device product line and continue to provide innovative devices for the treatment of vertebral compression fractures.

The new series of financing was completed in conjunction with existing investors who support Osseon's vision of becoming a preeminent spine company. "This infusion of capital will allow us to continue to develop our patented Orthopedic products and will propel us to the next level of commercial success," said CEO, Ron Clough.

About Osseon:

Osseon Therapeutics, Inc., headquartered in Santa Rosa, CA, is dedicated to developing and commercializing state of the art medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures. The company's patented, steerable delivery system offers more treatment options than other commercial solutions as well as offering significant advantages in procedural efficiency and cost. By improving the treatment of compression fractures within the thoracic and lumbar vertebral spine, Osseon offers new, forward thinking solutions to patients suffering from these maladies, as well as to the physicians and medical facilities that treat them. Osseon's products are distributed globally.

For more information, visit our website at osseon.com.

Osseon® is a registered trademark of Osseon Therapeutics, Inc. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

SOURCE Osseon Therapeutics, Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->